09:25 EDT AbbVie: Discontinuing development of ABBV-916 as standalone antibody
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie Reports Second-Quarter 2024 Financial Results
- Options Volatility and Implied Earnings Moves Today, July 25, 2024
- Frontier Medicines announces milestone payment in AbbVie partnership
- ABBV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Options Volatility and Implied Earnings Moves This Week, July 22 – July 26, 2024